NCT07424833
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07424833
Title A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ascentage Pharma Group Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
START Los Angele RECRUITING Los Angeles California 90025 United States Details
Mayo Clinic NOT_YET_RECRUITING Jacksonville Florida 32224 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
START New Jersey RECRUITING East Brunswick New Jersey 08816 United States Details
The University of TX MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030 United States Details
Henan Cancer Hospital RECRUITING Zhengzhou Henan China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field